Lv41
506 积分 2024-10-28 加入
CD70-specific CAR T cells have potent activity against acute myeloid leukemia without HSC toxicity
2小时前
待确认
Multiple molecular mechanisms underlying trastuzumab and lapatinib resistance in JIMT-1 breast cancer cells
5天前
已完结
ORM-6151: A First-in-Class, Anti-CD33 Antibody-Enabled GSPT1 Degrader for AML
7天前
已完结
Natural-source payloads used in the conjugated drugs architecture for cancer therapy: Recent advances and future directions
19天前
已完结
Optimizing the safety of antibody–drug conjugates for patients with solid tumours
19天前
已完结
Exploring the next generation of antibody–drug conjugates
19天前
已完结
Preclinical studies of an innovative 5T4-ADC ACR246 with the potential to better treat 5T4-positive solid tumors
1个月前
已关闭
Targeting DNA Topoisomerase I for the Treatment of Cancer: Past, Present and Future
3个月前
已完结
Navigating the clinical progress of antibody-drug conjugates: Emerging opportunities and remaining challenges
3个月前
已完结
Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer
4个月前
已完结
皖公网安备34019202002308
